Literature DB >> 26571452

Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: Method validation and application to a neonatal pharmacokinetic study.

Sarah F Cook1, Amber D King2, John N van den Anker3, Diana G Wilkins4.   

Abstract

Drug metabolism plays a key role in acetaminophen (paracetamol)-induced hepatotoxicity, and quantification of acetaminophen metabolites provides critical information about factors influencing susceptibility to acetaminophen-induced hepatotoxicity in clinical and experimental settings. The aims of this study were to develop, validate, and apply high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS) methods for simultaneous quantification of acetaminophen, acetaminophen-glucuronide, acetaminophen-sulfate, acetaminophen-glutathione, acetaminophen-cysteine, and acetaminophen-N-acetylcysteine in small volumes of human plasma and urine. In the reported procedures, acetaminophen-d4 and acetaminophen-d3-sulfate were utilized as internal standards (IS). Analytes and IS were recovered from human plasma (10μL) by protein precipitation with acetonitrile. Human urine (10μL) was prepared by fortification with IS followed only by sample dilution. Calibration concentration ranges were tailored to literature values for each analyte in each biological matrix. Prepared samples from plasma and urine were analyzed under the same HPLC-ESI-MS/MS conditions, and chromatographic separation was achieved through use of an Agilent Poroshell 120 EC-C18 column with a 20-min run time per injected sample. The analytes could be accurately and precisely quantified over 2.0-3.5 orders of magnitude. Across both matrices, mean intra- and inter-assay accuracies ranged from 85% to 112%, and intra- and inter-assay imprecision did not exceed 15%. Validation experiments included tests for specificity, recovery and ionization efficiency, inter-individual variability in matrix effects, stock solution stability, and sample stability under a variety of storage and handling conditions (room temperature, freezer, freeze-thaw, and post-preparative). The utility and suitability of the reported procedures were illustrated by analysis of pharmacokinetic samples collected from neonates receiving intravenous acetaminophen.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetaminophen/Paracetamol; Human plasma; Human urine; LC–MS/MS; Metabolites

Mesh:

Substances:

Year:  2015        PMID: 26571452     DOI: 10.1016/j.jchromb.2015.10.013

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Evident bias in a paracetamol metabolite population pharmacokinetic model applied to an external dataset.

Authors:  Jessica K Roberts; Matthew W Linakis; Xiaoxi Liu; Catherine M T Sherwin; John N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2018-04-17       Impact factor: 4.335

2.  Exposure to acetaminophen and all its metabolites upon 10, 15, and 20 mg/kg intravenous acetaminophen in very-preterm infants.

Authors:  Robert B Flint; Daniella W Roofthooft; Anne van Rongen; Richard A van Lingen; Johannes N van den Anker; Monique van Dijk; Karel Allegaert; Dick Tibboel; Catherijne A J Knibbe; Sinno H P Simons
Journal:  Pediatr Res       Date:  2017-06-21       Impact factor: 3.756

3.  Association of Prenatal Acetaminophen Exposure Measured in Meconium With Adverse Birth Outcomes in a Canadian Birth Cohort.

Authors:  Brennan H Baker; Heather H Burris; Tessa R Bloomquist; Amélie Boivin; Virginie Gillet; Annie Larouche; Larissa Takser; Jean-Philippe Bellenger; Jean-Charles Pasquier; Andrea A Baccarelli
Journal:  Front Pediatr       Date:  2022-04-05       Impact factor: 3.569

4.  Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic Model.

Authors:  Sarah F Cook; Chris Stockmann; Samira Samiee-Zafarghandy; Amber D King; Nina Deutsch; Elaine F Williams; Diana G Wilkins; Catherine M T Sherwin; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

5.  Simultaneous determination of acetaminophen and oxycodone in human plasma by LC-MS/MS and its application to a pharmacokinetic study.

Authors:  Wei Lu; Shunbo Zhao; Meng Gong; Luning Sun; Li Ding
Journal:  J Pharm Anal       Date:  2018-01-31

6.  Quantitation of paracetamol by liquid chromatography-mass spectrometry in human plasma in support of clinical trial.

Authors:  Richard Kin-Ting Kam; Michael Ho-Ming Chan; Hiu-Ting Wong; Aniruddha Ghose; Arjen M Dondorp; Katherine Plewes; Joel Tarning
Journal:  Future Sci OA       Date:  2018-08-15

7.  Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study.

Authors:  Sissel Sundell Haslund-Krog; Steen Hertel; Kim Dalhoff; Susanne Poulsen; Ulla Christensen; Diana Wilkins; John van den Anker; Tine Brink Henriksen; Helle Holst
Journal:  BMJ Paediatr Open       Date:  2019-03-30

8.  Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen.

Authors:  Anne van Rongen; Pyry A J Välitalo; Mariska Y M Peeters; Djamila Boerma; Fokko W Huisman; Bert van Ramshorst; Eric P A van Dongen; Johannes N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

9.  An ultra-rapid drug screening method for acetaminophen in blood serum based on probe electrospray ionization-tandem mass spectrometry.

Authors:  Kiyotaka Usui; Haruka Kobayashi; Yuji Fujita; Eito Kubota; Tomoki Hanazawa; Tomohiro Yoshizawa; Yoshito Kamijo; Masato Funayama
Journal:  J Food Drug Anal       Date:  2019-02-22       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.